Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
6.
J Pediatr ; 148(4): 552-5, 2006 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-16647423

RESUMO

Occipital brain injury associated with neonatal hypoglycemia can result in long-term disability, epilepsy, and visual impairment. The etiology of this pattern of injury is unclear; however, transient hyperinsulinism may be an independent risk factor. Magnetic resonance brain imaging can delineate the extent of brain injury and guide follow-up.


Assuntos
Encefalopatias Metabólicas/patologia , Hipoglicemia/congênito , Hipoglicemia/complicações , Lobo Occipital/lesões , Lobo Occipital/patologia , Encefalopatias Metabólicas/etiologia , Humanos , Hiperinsulinismo/complicações , Recém-Nascido , Imageamento por Ressonância Magnética
7.
J Perinat Med ; 33(6): 519-23, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-16318615

RESUMO

OBJECTIVE: To compare neonatal results from patients with gestational diabetes mellitus (GDM) who were treated with insulin, glyburide and acarbose. RESULTS: Seventy patients diagnosed with GDM who needed therapy to complement diet and physical activities were included in the study. One group was assigned to insulin therapy (n = 27), a second group was assigned to glyburide therapy (n = 24) and a third group was assigned to acarbose therapy (n = 19). Maternal characteristics were similar in the three groups. Glucose control was not achieved in five (20.8%) of the patients using glyburide and in eight (42.1%) of patients using acarbose. No statistical difference was observed in fasting and post-prandial glucose levels or in average newborn weight in the three groups. The rate of large for gestational age (LGA) fetuses was 3.7, 25 and 10.5% in the groups treated with insulin, glyburide and acarbose, respectively. Neonatal hypoglycemia was observed in eight newborns, six of which from the glyburide group. CONCLUSION: We believe that glyburide and acarbose can be promising alternative therapies for the treatment of GDM. Glyburide controlled glucose levels in most patients and it was more efficient than acarbose. Glyburide showed a higher rate of macrosomia and neonatal hypoglycemia as compared to other therapies.


Assuntos
Diabetes Gestacional/tratamento farmacológico , Hipoglicemiantes/administração & dosagem , Acarbose/administração & dosagem , Acarbose/efeitos adversos , Administração Oral , Adulto , Peso ao Nascer , Glicemia/metabolismo , Diabetes Gestacional/sangue , Feminino , Macrossomia Fetal/etiologia , Glibureto/administração & dosagem , Glibureto/efeitos adversos , Humanos , Hipoglicemia/congênito , Hipoglicemia/etiologia , Hipoglicemiantes/efeitos adversos , Recém-Nascido , Insulina/efeitos adversos , Insulina/uso terapêutico , Gravidez , Resultado da Gravidez
8.
Cochabamba; s.n; 1987. 6 p. ilus.
Não convencional em Espanhol | LILACS, LIBOCS, LIBOSP | ID: lil-202098

RESUMO

Durante los dos meses que duró el estudio se realizaron 360 nacimientos, 34 de los cuales fueron obtenidos por inducción o conducción. A pesar del tiempo corto del estudio y del reducido tamaño de la muestra, se concluye que el empléo de inducto-conducción del parto, no es un factor preponderante o si se quiere relievante en la producción de alteraciones en los niveles normales de la glicemia del recien nacido. Pero si se observa que hay una relación inversa entre tiempo de inducción y glicemia.


Assuntos
Humanos , Masculino , Feminino , Recém-Nascido , Glicemia/análise , Glicemia/efeitos dos fármacos , Hipoglicemia/congênito , Trabalho de Parto Induzido/efeitos adversos , Hipoglicemia/complicações
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA